CHA Biotech Co. Ltd (085660) — Cash Flow Reinvestment Rate

Latest as of June 2024: 3.80x

CHA Biotech Co. Ltd (085660) has a Cash Flow Reinvestment Rate of 3.80x as of June 2024, reinvesting ₩52.39 Billion (capex ₩34.71 Billion plus investments ₩17.68 Billion) from operating cash flow of ₩13.77 Billion. See CHA Biotech Co. Ltd (085660) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

3.80x
(Capex + Investments) / Operating CF

Total Reinvested

₩52.39 Billion
Capex + Investments

Operating Cash Flow

₩13.77 Billion
KRW

Capital Expenditures

₩34.71 Billion
KRW

CHA Biotech Co. Ltd Cash Flow Reinvestment Rate (2009–2023)

Historical reinvestment intensity for CHA Biotech Co. Ltd across 13 annual periods. For the full cash flow conversion analysis, see CHA Biotech Co. Ltd (085660) cash flow conversion.

Annual Cash Flow Reinvestment Rate for CHA Biotech Co. Ltd (2009–2023)

Year-by-year capital reinvestment analysis for CHA Biotech Co. Ltd. See 085660 financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2023 13.73x ₩158.10 Billion ₩11.51 Billion ₩74.38 Billion ▲ +35.2%
2021 10.16x ₩225.77 Billion ₩22.23 Billion ₩115.46 Billion ▲ +197.5%
2020 3.41x ₩160.41 Billion ₩47.00 Billion ₩126.23 Billion ▼ -42.8%
2019 5.97x ₩150.74 Billion ₩25.24 Billion ₩107.77 Billion ▲ +427.0%
2018 1.13x ₩85.43 Billion ₩75.38 Billion ₩78.14 Billion ▼ -75.9%
2017 4.70x ₩56.46 Billion ₩12.01 Billion ₩36.91 Billion ▼ -57.2%
2016 10.98x ₩124.04 Billion ₩11.29 Billion ₩34.13 Billion ▲ +1267.4%
2015 0.80x ₩49.69 Billion ₩61.86 Billion ₩31.36 Billion ▲ +91.4%
2013 0.42x ₩27.85 Billion ₩66.35 Billion ₩27.85 Billion ▼ -37.7%
2012 0.67x ₩30.84 Billion ₩45.77 Billion ₩30.84 Billion ▼ -8.2%
2011 0.73x ₩25.48 Billion ₩34.69 Billion ₩25.48 Billion ▲ +22.5%
2010 0.60x ₩25.22 Billion ₩42.07 Billion ₩25.22 Billion ▼ -19.7%
2009 0.75x ₩17.93 Billion ₩24.02 Billion ₩17.93 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow